D-0071-2024 Class III Terminated
FDA drug recall D-0071-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Oct 4, 2023 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 33,480 IV Bags.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 1, 2023
- Initiation Date
- Oct 4, 2023
- Termination Date
- Aug 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 33,480 IV Bags
Product description
VANCOmycin HCI PF, 1.25 g added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-028-68.
Reason for recall
Labeling: Not Elsewhere Classified
Distribution pattern
USA Nationwide
Code information
Lot#: 2330781, Exp. 10/19/23; 2330791, Exp. 10/29/23; 2330795, Exp. 11/02/23; 2330800, Exp. 11/09/23; 2330807, Exp. 11/11/23; 2330812, Exp. 11/16/23; 2330816, Exp. 11/19/23; 2330822, 10/20/23; 2330897,11/23/23; 2330899, 11/25/23; 2330901, 11/26/23; 2330918, 11/30/23; 2330943, 01/12/24; 2331050, 01/14/24; 2331064, 01/21/24; 2331102, Exp. 01/25/24.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0071-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026